SPALLONE, GIULIA
SPALLONE, GIULIA
Dipartimento di Medicina dei sistemi
A case of spontaneous regression of metastatic skin undifferentiated carcinoma
2021-01-01 Mazzeo, M; Silvaggio, D; Lozzi, F; Spallone, G; Lombardo, P; Di Raimondo, C; Cerroni, L; Bianchi, L
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias
2010-05-03 Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A
Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab
2021-01-01 Spallone, G; Ventura, A; Mazzeo, M; Di Raimondo, C; Lombardo, P; Silvaggio, D; Bianchi, L
Cutaneous mastocytosis: a dermatological perspective
2021-02-01 Di Raimondo, C; Del Duca, E; Silvaggio, D; Di Prete, M; Lombardo, P; Mazzeo, M; Spallone, G; Campione, E; Botti, E; Bianchi, L
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis
2012-09-01 Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations
2014-11-01 Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas
2011-01-01 Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, Pd; De Nicola, F; Ganci, F; Castrignano, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A
Efalizumab
2011-01-01 Talamonti, M; Spallone, G; Di Stefani, A; Costanzo, A; Chimenti, S
Effects of short-term aerobic exercise in a mouse model of Niemann-Pick type C disease on synaptic and muscle plasticity
2019-01-01 Palmieri, M; Cariati, I; Scimeca, M; Pallone, G; Bonanno, E; Tancredi, V; D'Arcangelo, G; Frank, C
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities
2019-10-12 Spallone, G; Sollena, P; Ventura, A; Fargnoli, Mc; Gutierrez, C; Piccerillo, A; Tambone, S; Bianchi, L; Peris, K
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers
2009-01-01 Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy
2009-01-01 Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving
2020-07-25 Di Raimondo, C; Mazzeo, M; Di Prete, M; Lombardo, P; Silvaggio, D; Del Duca, E; Bianchi, L; Spallone, G
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis
2013-01-01 Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature
2020-01-01 Campione, E; Di Prete, M; Lozzi, F; Lanna, C; Spallone, G; Mazzeo, M; Cosio, T; Rapanotti, C; Dika, E; Gaziano, R; Orlandi, A; Bianchi, L
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis
2009-01-01 Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S
Image Gallery: Peculiar subungual localization of a second primary melanoma during BRAF inhibitors treatment for metastatic melanoma: case report
2019-05-01 Ventura, A; Pitocco, R; Di Stefani, A; Cota, C; Spallone, D; Bianchi, L; Spallone, G
Leflunomide-induced DRESS syndrome
2016-01-01 Spallone, G; DI STEFANI, A; Sarmati, L; Sordillo, P; Bianchi, L
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146
2017-01-01 Rapanotti, M; Campione, E; Spallone, G; Orlandi, A; Bernardini, S; Bianchi, L
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis
2012-09-01 Spallone, G; Botti, E; Talamonti, M; Marinari, B; Pinetti, V; Chimenti, S; Costanzo, A
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2021 | A case of spontaneous regression of metastatic skin undifferentiated carcinoma | Mazzeo, M; Silvaggio, D; Lozzi, F; Spallone, G; Lombardo, P; Di Raimondo, C; Cerroni, L; Bianchi, L | Articolo su rivista | |
3-mag-2010 | A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias | Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A | Articolo su rivista | |
1-gen-2021 | Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab | Spallone, G; Ventura, A; Mazzeo, M; Di Raimondo, C; Lombardo, P; Silvaggio, D; Bianchi, L | Articolo su rivista | |
1-feb-2021 | Cutaneous mastocytosis: a dermatological perspective | Di Raimondo, C; Del Duca, E; Silvaggio, D; Di Prete, M; Lombardo, P; Mazzeo, M; Spallone, G; Campione, E; Botti, E; Bianchi, L | Articolo su rivista | |
1-set-2012 | Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis | Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A | Intervento a convegno | |
1-nov-2014 | Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations | Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2011 | Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas | Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, Pd; De Nicola, F; Ganci, F; Castrignano, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A | Articolo su rivista | |
1-gen-2011 | Efalizumab | Talamonti, M; Spallone, G; Di Stefani, A; Costanzo, A; Chimenti, S | Articolo su rivista | |
1-gen-2019 | Effects of short-term aerobic exercise in a mouse model of Niemann-Pick type C disease on synaptic and muscle plasticity | Palmieri, M; Cariati, I; Scimeca, M; Pallone, G; Bonanno, E; Tancredi, V; D'Arcangelo, G; Frank, C | Articolo su rivista | |
12-ott-2019 | Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities | Spallone, G; Sollena, P; Ventura, A; Fargnoli, Mc; Gutierrez, C; Piccerillo, A; Tambone, S; Bianchi, L; Peris, K | Articolo su rivista | |
1-gen-2009 | Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers | Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
1-gen-2009 | Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy | Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
25-lug-2020 | Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving | Di Raimondo, C; Mazzeo, M; Di Prete, M; Lombardo, P; Silvaggio, D; Del Duca, E; Bianchi, L; Spallone, G | Articolo su rivista | |
1-gen-2013 | Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis | Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2020 | High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature | Campione, E; Di Prete, M; Lozzi, F; Lanna, C; Spallone, G; Mazzeo, M; Cosio, T; Rapanotti, C; Dika, E; Gaziano, R; Orlandi, A; Bianchi, L | Articolo su rivista | |
1-gen-2009 | HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis | Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S | Intervento a convegno | |
1-mag-2019 | Image Gallery: Peculiar subungual localization of a second primary melanoma during BRAF inhibitors treatment for metastatic melanoma: case report | Ventura, A; Pitocco, R; Di Stefani, A; Cota, C; Spallone, D; Bianchi, L; Spallone, G | Articolo su rivista | |
1-gen-2016 | Leflunomide-induced DRESS syndrome | Spallone, G; DI STEFANI, A; Sarmati, L; Sordillo, P; Bianchi, L | Articolo su rivista | |
1-gen-2017 | Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 | Rapanotti, M; Campione, E; Spallone, G; Orlandi, A; Bernardini, S; Bianchi, L | Articolo su rivista | |
1-set-2012 | Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis | Spallone, G; Botti, E; Talamonti, M; Marinari, B; Pinetti, V; Chimenti, S; Costanzo, A | Intervento a convegno |